Supplementary Figure 3 from The CXCR2 Antagonist, SCH-527123, Shows Antitumor Activity and Sensitizes Cells to Oxaliplatin in Preclinical Colon Cancer Models

Authors :: Heinz-Josef Lenz
Robert D. Ladner
Nicos A. Petasis
Stan G. Louie
Kalyan C. Nagulapalli Venkata
David O. Rosenberg
David Paez
Leonor Benhaim
Dongyun Yang
Armin Gerger
Pierre O. Bohanes
Wu Zhang
Melissa J. Labonte
Yan Ning
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: PDF file, 570K, ERCC1 mRNA expression in colon cancer cell lines.

Full Text Access

Tools